NEW YORK, February 21, 2017 /PRNewswire/ --
On Friday, February 17, 2017, the NASDAQComposite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Meanwhile, US markets stretched on both sides as four sectors ended last Friday's trading session in bullish territories, four sectors in bearish colors,
Varian Medical Systems
Palo Alto, California headquartered Varian Medical Systems Inc.'s stock finished Friday's session 2.05% higher at $83.61 with a total volume of 2.13 million shares traded. Over the last one month and the previous three months, Varian Medical Systems' shares have gained 7.50% in the past one year. The Company's shares are trading below its 50-day and 200-day moving averages by 4.18% and 6.47%, respectively. Shares of Varian Medical Systems, which designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide, are trading at a PE ratio of 23.86. The stock has a Relative Strength Index (RSI) of 50.24.
On January 27th, 2017, research firm Barrington Research reiterated its 'Outperform' rating on the Company's stock with a decrease of the target price from $102 a share to $98 a share. See our free and comprehensive research report on VAR at:
Amsterdam, the Netherlands headquartered Wright Medical Group N.V.'s stock edged 0.56% higher, to close the day at $26.96. The stock recorded a trading volume of 987,441 shares, which was above its three months average volume of 710,710 shares. Wright Medical Group's shares have gained 8.84% in the last one month, 16.06% in the previous three months, and 55.75% in the past one year. The Company's shares are trading 9.88% and 19.85% above its 50-day and 200-day moving averages, respectively. Additionally, shares of the Company, which designs, manufactures, markets, and sells orthopedic products in the US, Europe, and internationally, have an RSI of 74.61.
On February 15th, 2017, research firm Needham downgraded the Company's stock rating from 'Buy' to 'Hold'. WMGI free research report PDF is just a click away at:
On Friday, shares in Marietta, Georgia headquartered MiMedx Group Inc. ended the session 0.24% higher at $8.29 with a total volume of 543,756 shares traded. MiMedx Group's shares have advanced 2.60% in the last one month and 5.20% in the previous one year. Shares of the Company, which develops, processes, and markets patent protected and proprietary regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues, and human skin and bone, are trading at a PE ratio of 46.84. The stock is trading 0.83% above its 200-day moving average. Moreover, the Company's shares have an RSI of 53.34. Sign up for your complimentary report on MDXG at:
On Friday, shares in San Diego, California headquartered NuVasive Inc. recorded a trading volume of 469,119 shares. The stock ended the day 0.34% higher at $74.22. Shares of the Company, which develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery, are trading at a PE ratio of 94.19. NuVasive's stock has gained 6.04% in the last one month and 19.32% in the previous three months. Furthermore, the stock has rallied 90.55% in the past one year. The Company is trading above its 50-day and 200-day moving averages by 7.27% and 17.02%, respectively. Furthermore, NuVasive's shares have an RSI of 67.24. Register for free on Stock-Callers.com and download the latest research report on NUVA at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: firstname.lastname@example.org Phone number: +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Angiogenesis is the process of formation of new blood vessels from pre-existing blood vessels. It ...
Aniridia is a genetic eye disorder in which the iris is partially or entirely absent. It is ...
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...View All